New drugs for Clostridium difficile infection

Editorial

John G Bartlett. Clin Infect Dis. 2006.

. 2006 Aug 15;43(4):428-31.

doi: 10.1086/506387. Epub 2006 Jul 11.

No abstract available

Comment on

Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
Louie TJ, Peppe J, Watt CK, Johnson D, Mohammed R, Dow G, Weiss K, Simon S, John JF Jr, Garber G, Chasan-Taber S, Davidson DM; Tolevamer Study Investigator Group. Louie TJ, et al. Clin Infect Dis. 2006 Aug 15;43(4):411-20. doi: 10.1086/506349. Epub 2006 Jul 11. Clin Infect Dis. 2006. PMID: 16838228 Clinical Trial.
Nitazoxanide for the treatment of Clostridium difficile colitis.
Musher DM, Logan N, Hamill RJ, Dupont HL, Lentnek A, Gupta A, Rossignol JF. Musher DM, et al. Clin Infect Dis. 2006 Aug 15;43(4):421-7. doi: 10.1086/506351. Epub 2006 Jul 11. Clin Infect Dis. 2006. PMID: 16838229 Clinical Trial.